Pathogenesis of so-called diffuse vascular or collagen disease.

Pathogenesis of so-called diffuse vascular or collagen disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pathogenesis of so-called diffuse vascular or collagen disease. Abstract Text:

K YARUMIAN,J KLEINERMAN,

Pathogenesis of so-called diffuse vascular or collagen disease. Publishing Authors By Initials

K YARUMIAN,J KLEINERMAN,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pathogenesis of so-called diffuse vascular or collagen disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archivio di medicina interna

VOLUME: 83

Page Numbers: 1-26

Journal Abbreviation:

ISSN: 0004-010X

DAY: 27

MONTH: Jan

YEAR: 1949

Pathogenesis of so-called diffuse vascular or collagen disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 421741

Pathogenesis of so-called diffuse vascular or collagen disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pathogenesis of so-called diffuse vascular or collagen disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pathogenesis of so-called diffuse vascular or collagen disease.

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Med Interna

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pathogenesis of so-called diffuse vascular or collagen disease Related Publications

• Bone Marrow Subsets Differentiate into Endothelial Cells and Pericytes Contributing to Ewing's Tumor Vessels.
• Cancer risks following diagnostic and therapeutic radiation exposure in children.
• Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers.
• Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
• Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
• Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.
• Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma.
• Paraquat in the rabbit.
• Pathogenesis of so-called diffuse vascular or collagen disease.
• Some aspects of pulmonary pathology in the Syrian hamster.
• Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
• Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
• Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
• The Osterix Transcription Factor Down-Regulates Interleukin-1{alpha} Expression in Mouse Osteosarcoma Cells.
• VEGF(165) expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.
• VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
• VEGF165, but not VEGF189, Stimulates Vasculogenesis and Bone Marrow Cell Migration into Ewing's Sarcoma Tumors In vivo.